© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Avid Bioservices, Inc. (CDMO) stock remained unchanged at $12.49 a share on NASDAQ. The stock opened at $12.49, fluctuating between $12.49 to $12.49 during the session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 05, 2025 | 12.49 | 12.49 | 12.49 | 12.49 | 0 |
| Feb 04, 2025 | 12.49 | 12.51 | 12.47 | 12.49 | 3.07M |
| Feb 03, 2025 | 12.48 | 12.49 | 12.47 | 12.48 | 1.03M |
| Jan 31, 2025 | 12.48 | 12.50 | 12.47 | 12.48 | 2.51M |
| Jan 30, 2025 | 12.45 | 12.47 | 12.44 | 12.46 | 1.44M |
| Jan 29, 2025 | 12.43 | 12.46 | 12.43 | 12.44 | 512.6K |
| Jan 28, 2025 | 12.45 | 12.46 | 12.43 | 12.43 | 333K |
| Jan 27, 2025 | 12.41 | 12.45 | 12.41 | 12.45 | 703.6K |
| Jan 24, 2025 | 12.45 | 12.46 | 12.42 | 12.42 | 640.4K |
| Jan 23, 2025 | 12.44 | 12.46 | 12.39 | 12.45 | 1.97M |
| Jan 22, 2025 | 12.45 | 12.47 | 12.42 | 12.45 | 1.89M |
| Jan 21, 2025 | 12.40 | 12.46 | 12.39 | 12.46 | 1.51M |
| Jan 17, 2025 | 12.38 | 12.41 | 12.37 | 12.39 | 1.64M |
| Jan 16, 2025 | 12.39 | 12.40 | 12.38 | 12.38 | 1.52M |
| Jan 15, 2025 | 12.40 | 12.43 | 12.37 | 12.39 | 3.26M |
| Jan 14, 2025 | 12.43 | 12.44 | 12.42 | 12.42 | 1.57M |
| Jan 13, 2025 | 12.39 | 12.45 | 12.39 | 12.43 | 832.9K |
| Jan 10, 2025 | 12.37 | 12.42 | 12.37 | 12.41 | 1.15M |
| Jan 08, 2025 | 12.36 | 12.41 | 12.35 | 12.38 | 1.51M |
| Jan 07, 2025 | 12.35 | 12.38 | 12.34 | 12.36 | 1.08M |
Avid Bioservices, Inc. operates as a Contract Development and Manufacturing Organization (CDMO), specializing in the development and CGMP-compliant production of biopharmaceutical drug substances. Their core expertise lies in compounds derived from mammalian cell culture, providing both clinical and commercial scale manufacturing solutions. The company is proficient in producing critical therapeutics such as monoclonal antibodies and recombinant proteins. Beyond manufacturing, their comprehensive service portfolio encompasses CGMP manufacturing for drug substances, bulk packaging, rigorous release and stability testing, and essential regulatory submission and support. Additionally, Avid Bioservices offers a range of process development services, including the optimization of upstream and downstream processes, alongside the development, testing, and characterization of analytical methods. Avid Bioservices primarily serves clients within the biotechnology and biopharmaceutical industries. The company, which was originally incorporated in 1981, was known as Peregrine Pharmaceuticals, Inc. before officially rebranding to Avid Bioservices, Inc. in January 2018. Its corporate headquarters are situated in Tustin, California.
| Employees | 371 |
| Beta | 1.41 |
| Sales or Revenue | $139.91M |
| 5Y Sales Change% | 1.104% |
| Fiscal Year Ends | April |
| Sector | Healthcare |
| Industry | Biotechnology |